# CareDx, Inc.: filings

CDNA · Nasdaq · CIK 1217234 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/cdna.md) · [Financials](/companies/cdna/financials.md) · [Filings](/companies/cdna/filings.md) · [Insiders](/companies/cdna/insiders.md)

## Reports and events: 255 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 773, 8-K 163, 144 65, SC 13G/A 46, 3 41, 10-Q 38, 4/A 28, SC 13G 25, S-8 17, CORRESP 15, DEFA14A 14, UPLOAD 14, DEF 14A 13, 10-K 12, 424B5 10, EFFECT 9, SCHEDULE 13G/A 8, CT ORDER 7, 8-K/A 6, S-1/A 6, ARS 5, SC 13D/A 5, POS AM 4, PRE 14A 4, S-1 4, 10-K/A 3, 10-Q/A 3, 424B3 3, D 3, NT 10-Q 3, S-3 3, S-3/A 3, S-3ASR 3, 424B4 2, CB 2, SC 13D 2, SCHEDULE 13G 2, SC TO-I/A 2, 3/A 1, 5 1, 8-A12B 1, CERTNAS 1, D/A 1, DRS 1, DRS/A 1, FWP 1, NT 10-K 1, POSASR 1, S-1MEF 1, SC TO-I 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-29 | 16:04 ET | [10-Q](/filings/0001217234-26-000061.md) | Quarterly report, period 2026-09-30 | 0001217234-26-000061 |
| 2026-10-29 | 16:02 ET | [8-K](/filings/0001217234-26-000059.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001217234-26-000059 |
| 2026-09-16 | 16:06 ET | [8-K/A](/filings/0001217234-26-000052.md) | 2.01 Completion of an acquisition or disposition; 9.01 Financial statements and exhibits | 0001217234-26-000052 |
| 2026-07-30 | 16:04 ET | [10-Q](/filings/0001217234-26-000046.md) | Quarterly report, period 2026-06-30 | 0001217234-26-000046 |
| 2026-07-30 | 16:03 ET | [8-K](/filings/0001217234-26-000045.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001217234-26-000045 |
| 2026-07-07 | 17:12 ET | [8-K](/filings/0001217234-26-000038.md) | 2.01 Completion of an acquisition or disposition; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001217234-26-000038 |
| 2026-06-15 | 16:15 ET | [8-K](/filings/0001217234-26-000036.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001217234-26-000036 |
| 2026-04-28 | 16:13 ET | [10-Q](/filings/0001217234-26-000033.md) | Quarterly report, period 2026-03-31 | 0001217234-26-000033 |
| 2026-04-28 | 16:05 ET | [8-K](/filings/0001104659-26-050317.md) | 1.01 Entry into a material agreement; 2.02 Results of operations; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-050317 |
| 2026-04-27 | 16:06 ET | [DEF 14A](/filings/0001217234-26-000028.md) | Proxy statement, period 2026-04-27 | 0001217234-26-000028 |
| 2026-04-23 | 16:12 ET | [8-K/A](/filings/0001217234-26-000024.md) | 5.02 Departure or appointment of officers or directors | 0001217234-26-000024 |
| 2026-04-16 | 06:05 ET | [8-K](/filings/0001104659-26-043970.md) | 1.01 Entry into a material agreement; 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-043970 |
| 2026-02-25 | 16:12 ET | [8-K/A](/filings/0001217234-26-000019.md) | 2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001217234-26-000019 |
| 2026-02-25 | 16:10 ET | [10-K](/filings/0001217234-26-000018.md) | Annual report, period 2025-12-31 | 0001217234-26-000018 |
| 2026-02-24 | 16:03 ET | [8-K](/filings/0001217234-26-000015.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001217234-26-000015 |
| 2026-01-12 | 07:08 ET | [8-K](/filings/0001217234-26-000007.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001217234-26-000007 |
| 2025-12-18 | 17:00 ET | [8-K](/filings/0001217234-25-000072.md) | 8.01 Other events | 0001217234-25-000072 |
| 2025-12-15 | 16:02 ET | [8-K](/filings/0001217234-25-000068.md) | 5.03 Amendment to articles or bylaws | 0001217234-25-000068 |
| 2025-11-04 | 16:13 ET | [10-Q](/filings/0001217234-25-000063.md) | Quarterly report, period 2025-09-30 | 0001217234-25-000063 |
| 2025-11-04 | 16:09 ET | [8-K](/filings/0001217234-25-000062.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001217234-25-000062 |
| 2025-10-24 | 16:06 ET | [8-K](/filings/0001217234-25-000051.md) | 5.02 Departure or appointment of officers or directors | 0001217234-25-000051 |
| 2025-08-06 | 16:11 ET | [10-Q](/filings/0001217234-25-000046.md) | Quarterly report, period 2025-06-30 | 0001217234-25-000046 |
| 2025-08-06 | 16:08 ET | [8-K](/filings/0001217234-25-000045.md) | 2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001217234-25-000045 |
| 2025-06-12 | 16:32 ET | [8-K](/filings/0001193125-25-139978.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001193125-25-139978 |
| 2025-06-03 | 16:30 ET | [8-K](/filings/0001193125-25-134150.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-134150 |
| 2025-04-30 | 16:18 ET | [10-Q](/filings/0001217234-25-000037.md) | Quarterly report, period 2025-03-31 | 0001217234-25-000037 |
| 2025-04-30 | 16:11 ET | [8-K](/filings/0001217234-25-000036.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001217234-25-000036 |
| 2025-04-28 | 21:01 ET | [DEF 14A](/filings/0001217234-25-000025.md) | Proxy statement, period 2025-06-12 | 0001217234-25-000025 |
| 2025-03-28 | 17:06 ET | [8-K](/filings/0001217234-25-000016.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001217234-25-000016 |
| 2025-02-28 | 17:49 ET | [10-K](/filings/0001217234-25-000012.md) | Annual report, period 2024-12-31 | 0001217234-25-000012 |
| 2025-02-26 | 16:09 ET | [8-K](/filings/0001217234-25-000007.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001217234-25-000007 |
| 2025-01-13 | 07:00 ET | [8-K](/filings/0001193125-25-004941.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-004941 |
| 2025-01-08 | 16:30 ET | [8-K](/filings/0001193125-25-003535.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-25-003535 |
| 2024-11-04 | 16:18 ET | [10-Q](/filings/0001217234-24-000103.md) | Quarterly report, period 2024-09-30 | 0001217234-24-000103 |
| 2024-11-04 | 16:10 ET | [8-K](/filings/0001217234-24-000101.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001217234-24-000101 |
| 2024-10-15 | 07:56 ET | [8-K](/filings/0001193125-24-237218.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-24-237218 |
| 2024-10-08 | 10:00 ET | [8-K](/filings/0001193125-24-234155.md) | 8.01 Other events | 0001193125-24-234155 |
| 2024-10-04 | 16:05 ET | [8-K](/filings/0001217234-24-000089.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001217234-24-000089 |
| 2024-09-12 | 07:04 ET | [8-K](/filings/0001193125-24-217626.md) | 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-24-217626 |
| 2024-07-31 | 16:16 ET | [10-Q](/filings/0001217234-24-000083.md) | Quarterly report, period 2024-06-30 | 0001217234-24-000083 |
| 2024-07-31 | 16:10 ET | [8-K](/filings/0001217234-24-000081.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001217234-24-000081 |
| 2024-06-18 | 15:56 ET | [8-K](/filings/0001217234-24-000071.md) | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001217234-24-000071 |
| 2024-05-09 | 16:14 ET | [10-Q](/filings/0001217234-24-000064.md) | Quarterly report, period 2024-03-31 | 0001217234-24-000064 |
| 2024-05-09 | 16:09 ET | [8-K](/filings/0001217234-24-000062.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001217234-24-000062 |
| 2024-04-29 | 16:19 ET | [DEF 14A](/filings/0001217234-24-000042.md) | Proxy statement, period 2024-06-13 | 0001217234-24-000042 |
| 2024-04-16 | 16:20 ET | [8-K](/filings/0001193125-24-097776.md) | 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-24-097776 |
| 2024-03-11 | 16:02 ET | [8-K](/filings/0001193125-24-064783.md) | 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-24-064783 |
| 2024-02-28 | 16:27 ET | [10-K](/filings/0001217234-24-000033.md) | Annual report, period 2023-12-31 | 0001217234-24-000033 |
| 2024-02-28 | 16:16 ET | [8-K](/filings/0001217234-24-000032.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001217234-24-000032 |
| 2024-01-09 | 07:10 ET | [8-K](/filings/0001193125-24-004834.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-24-004834 |

Page 1 of 6. [Older](/companies/cdna/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 29, 2026, 16:39 ET. No prices; not investment advice.